Cargando…
One carbon metabolism in human lung cancer
BACKGROUND: Lung cancer remains the major cause of cancer related death worldwide. The discovery of targeted therapies against activating mutations in genes like EGFR considerably improved the prognosis for a subgroup of patients but still leaves a large part without a targeted therapy. One carbon m...
Autores principales: | Yao, Sha, Peng, Luogen, Elakad, Omar, Küffer, Stefan, Hinterthaner, Marc, Danner, Bernhard C., von Hammerstein-Equord, Alexander, Ströbel, Philipp, Bohnenberger, Hanibal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264328/ https://www.ncbi.nlm.nih.gov/pubmed/34295659 http://dx.doi.org/10.21037/tlcr-20-1039 |
Ejemplares similares
-
Role of Annexin A1 in Squamous Cell Lung Cancer Progression
por: Elakad, Omar, et al.
Publicado: (2021) -
Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma
por: Li, Yuchan, et al.
Publicado: (2022) -
Expression and prognostic impact of DNA-PK in human lung cancer
por: Tirilomi, Anna, et al.
Publicado: (2023) -
Expression and prognostic impact of CD49b in human lung cancer
por: Tirilomi, Anna, et al.
Publicado: (2022) -
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
por: Elakad, Omar, et al.
Publicado: (2022)